Jasper Therapeutics Inc Cash Flow Quality Index

Latest as of March 2020: -0.16x

Jasper Therapeutics Inc cash flow quality index. Jasper Therapeutics Inc (JSPR) has a Cash Flow Quality Index of -0.16x as of March 2020. Operating cash flow of $-232.87K is below net income of $1.43 Million, suggesting accrual-heavy earnings not yet converted to cash. See Jasper Therapeutics Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-0.16x

Operating CF / Net Income

Operating Cash Flow

$-232.87K

USD

Net Income

$1.43 Million

USD

Data as of

Mar 2020

Most recent filing

Jasper Therapeutics Inc Cash Flow Quality Index by Year (None–None)

Jasper Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Jasper Therapeutics Inc. For the full cash flow conversion analysis, see JSPR operating cash flow.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.